BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6232913)

  • 1. Neuroendocrinologic findings in patients with untreated Huntington's chorea.
    Caraceni TA; Parati EA; Giovannini PM; Grassi MP; Scigliano G; Carella F; Müller EE
    Arch Neurol; 1984 May; 41(5):516-20. PubMed ID: 6232913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone and prolactin secretion in Huntington's disease.
    Levy CL; Carlson HE; Sowers JR; Goodlett RE; Tourtellotte WW; Hershman JM
    Life Sci; 1979 Feb; 24(8):743-9. PubMed ID: 155768
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea.
    Kartzinel R; Perlow MD; Carter AC; Chase TN; Calne DB; Shoulson I
    Trans Am Neurol Assoc; 1976; 101():53-6. PubMed ID: 141763
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea.
    Chalmers RJ; Johnson RH; Keogh HJ; Nanda RN
    J Neurol Neurosurg Psychiatry; 1978 Feb; 41(2):135-9. PubMed ID: 24678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute treatment of Huntington's chorea with lisuride.
    Frattola L; Albizzati MG; Alemani A; Bassi S; Ferrarese C; Trabucchi M
    J Neurol Sci; 1983 May; 59(2):247-53. PubMed ID: 6222164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone and prolactin release in Huntington's chorea.
    Chalmers RJ; Johnson RH; Nanda RN
    Lancet; 1977 Oct; 2(8042):824. PubMed ID: 71631
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
    Felt V; Nedvídková J
    Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
    [No Abstract]   [Full Text] [Related]  

  • 8. Impaired prolactin release in Huntington's chorea. Evidence for dopaminergic excess.
    Hayden MR; Vinik AI; Paul M; Beighton P
    Lancet; 1977 Aug; 2(8035):423-6. PubMed ID: 70642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone hyperresponsiveness to dopaminergic stimulation in Huntington's chorea.
    Müller EE; Parati EA; Panerai AE; Cocchi D; Caraceni T
    Neuroendocrinology; 1979; 28(5):313-9. PubMed ID: 155781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's disease.
    Durso R; Tamminga CA; Denaro A; Ruggeri S; Chase TN
    Neurology; 1983 Sep; 33(9):1229-32. PubMed ID: 6225034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin control in Huntington's chorea.
    Müller EE; Cocchi D; Mantegazza P; Parati EA; Caraceni T
    Lancet; 1977 Oct; 2(8041):764-5. PubMed ID: 71573
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of Huntington's chorea with bromocriptine.
    Frattola L; Albiazzati MG; Spano PF; Trabucchi M
    Acta Neurol Scand; 1977 Jul; 56(1):37-45. PubMed ID: 141860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington's chorea.
    Caraceni T; Panerai AE; Paratl EA; Cocchi D; Müller EE
    J Clin Endocrinol Metab; 1977 May; 44(5):870-5. PubMed ID: 140180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1982 Apr; 121(16):489-93. PubMed ID: 6807547
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of DA agonist in Huntington disease hyperkinesia.
    Caraceni TA; Girotti F; Giovannini P; Pederzoli M; Parati EA
    Ital J Neurol Sci; 1980 Jun; 1(3):155-61. PubMed ID: 6210644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of somatostatin on thyrotropin, prolactin, growth hormone and insulin responses to thyrotropin releasing hormone and arginine in healthy, hypothyroid and acromegalic subjects.
    Faure N; Dussault JH; Nadeau A; Szots F; Guyda H; Labrie F
    Can Med Assoc J; 1977 Sep; 117(5):478-81. PubMed ID: 409475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Huntington's chorea and somatotropic hormone: dynamic explorations in 27 cases (author's transl)].
    Destée A; Petit H; Fossati P; Warot P
    Rev Neurol (Paris); 1981; 137(1):21-31. PubMed ID: 6453416
    [No Abstract]   [Full Text] [Related]  

  • 18. Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia.
    Nemeroff CB; Youngblood WW; Manberg PJ; Prange AJ; Kizer JS
    Science; 1983 Sep; 221(4614):972-5. PubMed ID: 6136092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lisuride hydrogen maleate: evidence for a long lasting dopaminergic activity in humans.
    Liuzzi A; Chiodini PG; Oppizzi G; Botalla L; Verde G; De Stefano L; Colussi G; Gräf KJ; Horowski R
    J Clin Endocrinol Metab; 1978 Feb; 46(2):196-202. PubMed ID: 108287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone release in depressed patients before and after recovery.
    Grégoire F; Brauman H; De Buck R; Corvilain J
    Psychoneuroendocrinology; 1977; 2(3):303-12. PubMed ID: 410051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.